Cleveland Clinic Cancer Advances

Unlocking Treatment Strategies for Anaplastic Thyroid Cancer

Cleveland Clinic Taussig Cancer Institute

Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.

0:00 | 21:26
Joseph Scharpf, MD, FACS, Director of Head and Neck Endocrine Surgery at the Cleveland Clinic Head and Neck Institute, and Emrullah Yilmaz, MD, PhD, an oncologist at Cleveland Clinic Taussig Cancer Institute, specializing in head and neck cancers, join the Cancer Advances podcast to discuss their study that provides insights to treatment strategies and tumor characteristics of anaplastic thyroid cancer. Listen as Dr. Scharpf and Dr. Yilmaz discuss patients with BRAF mutations and Cleveland Clinic's collaborative approach for thyroid cancer care.